Aeterna Zentaris to Present at Oppenheimer 23rd Annual Healthcare Conference in New York

 Aeterna Zentaris to Present at Oppenheimer 23rd Annual Healthcare Conference
                                 in New York

PR Newswire

QUÉBEC CITY, Dec. 4, 2012

QUÉBEC CITY, Dec. 4, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS)
(TSX: AEZ) (the "Company") today announced that its Senior Vice President and
Chief Medical Officer, Paul Blake, MD, will be presenting a corporate overview
at the Oppenheimer 23^rd Annual Healthcare Conference on Thursday, December
13, 2012, at 9:25 am (Eastern), in the East Foyer of The Waldorf-Astoria Hotel
in New York City.

A live webcast of this presentation will be available on Aeterna Zentaris'
website at www.aezsinc.com, in the "Newsroom" section. A replay of the webcast
will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris

Aeterna Zentaris is an oncology and endocrinology drug development company
currently investigating treatments for various unmet medical needs. The
Company's pipeline encompasses compounds at all stages of development, from
drug discovery through to marketed products. For more information please visit
www.aezsinc.com.

SOURCE AETERNA ZENTARIS INC.

Contact:

Investor Relations
Ginette Beaudet Vallières
Investor Relations Coordinator
(418) 652-8525 ext. 265
gvallieres@aezsinc.com

Media Relations
Paul Burroughs
Director of Communications
(418) 652-8525 ext. 406
pburroughs@aezsinc.com